响应ROS的脂质纳米颗粒释放基于微环境调节的多功能水凝促进感染糖尿病伤口愈合
Hao Yang1, Dongming Lv1, Shanqiang Qu2
1Department of Burn and Wound Repair, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|September 23, 2024
概括
这项研究开发了新型反应性氧物种 (ROS) 反应性水凝,用于治疗糖尿病伤口. 水凝有效地根除了细菌,减少了炎症,并通过释放抗微生物和puerarin来促进愈合.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 伤口愈合 治愈 伤口愈合
背景情况:
- 糖尿病伤口患有微环境失衡,其特点是过度反应性氧物种 (ROS) 和受损的愈合.
- 慢性炎症,氧化应激和细菌感染是治疗糖尿病伤口的关键挑战.
研究的目的:
- 开发ROS响应的水凝,用于治疗慢性糖尿病感染的伤口.
- 评估水凝在调节伤口微环境和促进愈合方面的有效性.
主要方法:
- 使用丝纤维素甲基化 (SFMA),改性原体III型 (rCol3MA) 和脂质纳米粒子 (LNPs) 制造ROS响应的水凝.
- 纳入和控制释放的抗微生物 (AMP) 和 puerarin (PUE).
- 评估水凝的物理化学特性,生物相容性,抗菌活性,抗炎作用和血管调节.
主要成果:
- 开发的水凝系统表现出稳定的物理化学性能和出色的生物相容性.
- 水凝有效地根除了细菌,抑制了炎症反应,并调节了血管功能.
- 从水凝中释放AMP和PUE表明了对糖尿病伤口愈合的显著治疗效果.
结论:
- 多功能,ROS响应的水凝为治疗慢性糖尿病感染伤口提供了一个有希望和有效的策略.
- 这种创新的水凝系统为未来在伤口护理中的临床转化带来了巨大的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
Oral Hypoglycemic Agents: Biguanides and Glitazones
993
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
993
Glucagon-like Receptor Agonists
1.3K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Microbial Biosensors
88
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
88
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59


